These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 87401)

  • 1. DHT concentrations in human prostate cancer tissue.
    Geller J; Albert J; Loza D; Geller S; Stoeltzing W; de la Vega D
    J Clin Endocrinol Metab; 1978 Mar; 46(3):440-4. PubMed ID: 87401
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.
    Geller J; Albert J; Nachtsheim D; Loza D; Lippman S
    Prog Clin Biol Res; 1979; 33():103-11. PubMed ID: 93747
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydrotestosterone measured in core biopsies from prostatic tissues.
    Bruun E; Frandsen H; Nielsen K; Rasmussen LB; Vinnergaard T; Frimodt-Møller C
    Am J Clin Oncol; 1988; 11 Suppl 2():S27-9. PubMed ID: 2468272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone-dependency of the human prostate].
    Robel P
    Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
    Mobbs BG; Johnson IE; Connolly JG; Clark AF
    J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
    [No Abstract]   [Full Text] [Related]  

  • 6. Methodologic basis for the radioimmunoassay of endogenous steroids in human prostatic tissue.
    Belis JA
    Invest Urol; 1980 Jan; 17(4):332-6. PubMed ID: 6153177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
    Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
    J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endogenous androgen levels of human prostatic tissues].
    Morioka M; Takeda K; Mitsuhata N; Ohashi T; Ohmori H; Saito T; Kanbegawa A
    Nihon Naibunpi Gakkai Zasshi; 1982 Jul; 58(7):876-85. PubMed ID: 6182032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment.
    Barrack ER; Brendler CB; Walsh PC
    Prog Clin Biol Res; 1987; 243A():79-97. PubMed ID: 3309976
    [No Abstract]   [Full Text] [Related]  

  • 10. DHT in prostate cancer tissue--a guide to management and therapy.
    Geller J; Albert JD
    Prostate; 1985; 6(1):19-25. PubMed ID: 3969370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin in human prostate tissue.
    van Sande M; Van Camp K
    Urol Res; 1981; 9(5):241-4. PubMed ID: 6171084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
    Ewing LL; Berry SJ; Higginbottom EG
    Endocrinology; 1983 Dec; 113(6):2004-9. PubMed ID: 6196180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prostatic cancer tissue dihydrotestosterone levels at the time of relapse following orchiectomy or estrogen therapy.
    Geller J; Albert JD; Nachtsheim DA; Loza D
    J Urol; 1984 Oct; 132(4):693-6. PubMed ID: 6471215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of the prostate: early diagnosis by zinc and hormone analysis?
    Habib FK; Mason MK; Smith PH; Stitch SR
    Br J Cancer; 1979 Jun; 39(6):700-4. PubMed ID: 87214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on usefulness of the crude nuclear DHT measurement in prostatic cancer patients].
    Tohjoh S
    Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1327-35. PubMed ID: 2480469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
    BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone, dihydrotestosterone, and zinc concentrations in human testis and epididymis.
    Suescun MO; Campo S; Rivarola MA; González-Echeverría F; Scorticati C; Ghirlanda J; Tezón J; Blaquier JA; Calandra RS
    Arch Androl; 1981 Dec; 7(4):297-303. PubMed ID: 7316603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.